[HTML][HTML] mTOR as a central regulator of lifespan and aging

D Papadopoli, K Boulay, L Kazak, M Pollak… - …, 2019 - ncbi.nlm.nih.gov
The mammalian/mechanistic target of rapamycin (mTOR) is a key component of cellular
metabolism that integrates nutrient sensing with cellular processes that fuel cell growth and …

Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy

JL Carter, K Hege, J Yang, HA Kalpage, Y Su… - Signal transduction and …, 2020 - nature.com
Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults and the
second most common form of acute leukemia in children. Despite this, very little …

[HTML][HTML] Multi-organ proteomic landscape of COVID-19 autopsies

X Nie, L Qian, R Sun, B Huang, X Dong, Q Xiao… - Cell, 2021 - cell.com
The molecular pathology of multi-organ injuries in COVID-19 patients remains unclear,
preventing effective therapeutics development. Here, we report a proteomic analysis of 144 …

Targeting AKT/mTOR in oral cancer: mechanisms and advances in clinical trials

C Harsha, K Banik, HL Ang, S Girisa… - International journal of …, 2020 - mdpi.com
Oral cancer (OC) is a devastating disease that takes the lives of lots of people globally every
year. The current spectrum of treatment modalities does not meet the needs of the patients …

[HTML][HTML] mRNA cap regulation in mammalian cell function and fate

A Galloway, VH Cowling - Biochimica et Biophysica Acta (BBA)-Gene …, 2019 - Elsevier
In this review we explore the regulation of mRNA cap formation and its impact on
mammalian cells. The mRNA cap is a highly methylated modification of the 5′ end of RNA …

Ribosome collisions trigger cis-acting feedback inhibition of translation initiation

S Juszkiewicz, G Slodkowicz, Z Lin, P Freire-Pritchett… - Elife, 2020 - elifesciences.org
Translation of aberrant mRNAs can cause ribosomes to stall, leading to collisions with
trailing ribosomes. Collided ribosomes are specifically recognised by ZNF598 to initiate …

Rapamycin treatment during development extends life span and health span of male mice and Daphnia magna

AV Shindyapina, Y Cho, A Kaya, A Tyshkovskiy… - Science …, 2022 - science.org
Development is tightly connected to aging, but whether pharmacologically targeting
development can extend life remains unknown. Here, we subjected genetically diverse …

Ribosomal protein S6: a potential therapeutic target against cancer?

YW Yi, KS You, JS Park, SG Lee, YS Seong - International journal of …, 2021 - mdpi.com
Ribosomal protein S6 (RPS6) is a component of the 40S small ribosomal subunit and
participates in the control of mRNA translation. Additionally, phospho (p)-RPS6 has been …

Eukaryotic translation initiation factors as promising targets in cancer therapy

P Hao, J Yu, R Ward, Y Liu, Q Hao, S An… - Cell Communication and …, 2020 - Springer
The regulation of the translation of messenger RNA (mRNA) in eukaryotic cells is critical for
gene expression, and occurs principally at the initiation phase which is mainly regulated by …

Regulation of senescence traits by MAPKs

C Anerillas, K Abdelmohsen, M Gorospe - Geroscience, 2020 - Springer
A phenotype of indefinite growth arrest acquired in response to sublethal damage, cellular
senescence affects normal aging and age-related disease. Mitogen-activated protein …